These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11620377)
21. Patent license restrictions in the prescription drug industry. Miller HD Va Law Rev; 1967; 53(6):1283-313. PubMed ID: 11615190 [No Abstract] [Full Text] [Related]
22. The dirty little secret behind our drug laws. Monson MC Reason; 1980; 12(7):48-52. PubMed ID: 11615104 [No Abstract] [Full Text] [Related]
23. Self-dosage medicine in America, 1906 and 1981. Young JH South Atl Q; 1981; 80(4):379-90. PubMed ID: 11633218 [No Abstract] [Full Text] [Related]
24. Internal diversification and US regulatory controls in the pharmaceutical industry. Goedde AG Q Rev Econ Bus; 1982; 22(1):101-10. PubMed ID: 11632815 [No Abstract] [Full Text] [Related]
25. The impact of regulation on pharmaceutical research expenditures: a dynamic approach. Wiggins SN Econ Inq; 1983; 21(1):115-28. PubMed ID: 11631945 [No Abstract] [Full Text] [Related]
26. The political economy of the pharmaceutical industry. Comanor WS J Econ Lit; 1986; 24(3):1178-1217. PubMed ID: 11617316 [No Abstract] [Full Text] [Related]
27. Regulation and the choice of prescription drugs. Temin P Am Econ Rev; 1980; 70(2):301-5. PubMed ID: 11614163 [No Abstract] [Full Text] [Related]
28. [Public health in the city of Hamburg in the 19th century, with regard to medical legislation (1586--1818--1900)]. Rodegra H Sudhoffs Arch Z Wissenschaftsgesch Beih; 1979; 21():1-217. PubMed ID: 162512 [No Abstract] [Full Text] [Related]
29. Making governmental policy under conditions of scientific uncertainty: a century of controversy about saccharin in Congress and the laboratory. Priebe PM; Kauffman GB Minerva; 1980; 18(4):556-74. PubMed ID: 11611011 [No Abstract] [Full Text] [Related]
30. The fortunes of economic reform legislation: the case of the Drug Amendments Act of 1962. Steele H Am J Econ Sociol; 1966; 25(1):39-52. PubMed ID: 11613652 [No Abstract] [Full Text] [Related]
31. Three southern food and drug cases. Young JH J South Hist; 1983; 49(1):3-36. PubMed ID: 11614815 [No Abstract] [Full Text] [Related]
32. The regulation of patent medicines in the United States and France. Frey E Hist Sci Med; 1982; 17(Spec 2):244-7. PubMed ID: 11612299 [No Abstract] [Full Text] [Related]
33. The regulations of patent medicines in the United States and France. Frey EF Bookman; 1983; 10(1):3-6. PubMed ID: 11611177 [No Abstract] [Full Text] [Related]
34. Harvey W. Wiley and the Pure Food and Drug Act. Nutr Hist Notes; 1981; 11():2-4. PubMed ID: 11635476 [No Abstract] [Full Text] [Related]
35. The origin of compulsory drug prescriptions. Temin P J Law Econ; 1979; 22(1):91-106. PubMed ID: 11614760 [No Abstract] [Full Text] [Related]
36. Government actions in times of crisis: lessons from the history of drug regulation. Temin P J Soc Hist; 1985; 18(3):433-8. PubMed ID: 11617484 [No Abstract] [Full Text] [Related]
37. Estimating the effects of regulation on innovation: an international comparative analysis of the pharmaceutical industry. Grabowski HG; Vernon JM; Thomas LG J Law Econ; 1978; 21(1):133-63. PubMed ID: 11614761 [No Abstract] [Full Text] [Related]